mDataType,dataset_name,drug_name,sens_stat,estimate,pvalue,drug_id,tissue mRNA,CTRPv2,SNX-2112,AAC,-0.164284736438774,1.48245933813841e-06,649,pan-cancer mRNA,CTRPv2,ML162,AAC,-0.155985201930553,2.40136386598523e-05,453,pan-cancer mRNA,CTRPv2,1S,3R-RSL-3,AAC,-0.15182019297539,2.90528355527071e-05,4,pan-cancer mRNA,CTRPv2,AZD7762,AAC,-0.143541765151977,4.48737538796669e-05,58,pan-cancer mRNA,CTRPv2,ML210,AAC,-0.140786287934375,7.42711155532102e-05,455,pan-cancer mRNA,CTRPv2,pluripotin,AAC,-0.135013111152588,0.000359134718088488,567,pan-cancer mRNA,CTRPv2,cimetidine,AAC,0.220696418077824,0.0014014425700782,236,pan-cancer mRNA,CTRPv2,AT13387,AAC,-0.153811595389391,0.00141725329338468,40,pan-cancer mRNA,CTRPv2,CHIR-99021,AAC,-0.115961977534006,0.00183919236802564,223,pan-cancer mRNA,CTRPv2,BRD-K37390332,AAC,0.129340645415404,0.00205175989151501,136,pan-cancer mRNA,CTRPv2,BRD-K94991378,AAC,-0.129609590495948,0.00211835583629846,170,pan-cancer mRNA,CTRPv2,BRD-K71935468,AAC,-0.129057221011932,0.00230467962472281,159,pan-cancer mRNA,GDSC1000,SB590885,AAC,0.100721468186824,0.00296524930951581,615,pan-cancer mRNA,CCLE,PLX4720,AAC,0.13964051908191,0.00319727506087333,569,pan-cancer mRNA,CTRPv2,OSI-027,AAC,-0.110979502144418,0.00336979666283746,518,pan-cancer mRNA,CTRPv2,PLX4720,AAC,0.110722984916612,0.00340475643731506,569,pan-cancer mRNA,CTRPv2,GDC-0879,AAC,0.10877921771433,0.00418823899556557,312,pan-cancer mRNA,CTRPv2,ETP-46464,AAC,-0.128997217791208,0.0049237948161346,291,pan-cancer mRNA,CTRPv2,BMS-754807,AAC,-0.105520731479013,0.00556786510814595,91,pan-cancer mRNA,CTRPv2,MLN2480,AAC,0.151712299844514,0.00616663974507831,463,pan-cancer mRNA,CTRPv2,TG-101348,AAC,-0.101088528550756,0.00633499534484304,683,pan-cancer mRNA,CTRPv2,compound 1B,AAC,0.113009699755903,0.00634821479567057,242,pan-cancer mRNA,CTRPv2,BMS-536924,AAC,-0.104743459997065,0.0067502777597848,89,pan-cancer mRNA,GDSC1000,lapatinib,AAC,-0.130998139565824,0.00728626876353684,415,pan-cancer mRNA,CTRPv2,GDC-0941,AAC,-0.10483842076716,0.00752852908424937,313,pan-cancer mRNA,CTRPv2,Docetaxel,AAC,-0.131367406577658,0.0076577519148239,271,pan-cancer mRNA,CTRPv2,dabrafenib,AAC,0.129489202170253,0.00795033978805928,259,pan-cancer mRNA,CTRPv2,Vorinostat,AAC,0.0959840158703564,0.00819949299655507,725,pan-cancer mRNA,CTRPv2,CID-5951923,AAC,-0.110444161768667,0.00846563278657538,230,pan-cancer mRNA,CTRPv2,N9-isopropylolomoucine,AAC,-0.104258713388731,0.00897543959075943,472,pan-cancer mRNA,CTRPv2,canertinib,AAC,-0.102822996744771,0.00898543632264082,196,pan-cancer mRNA,CTRPv2,BRD-K99006945,AAC,0.144961307962753,0.00930319488549503,174,pan-cancer mRNA,GDSC1000,Cytarabine,AAC,0.0972017092698219,0.009711117162814,257,pan-cancer mRNA,CTRPv2,sirolimus:bortezomib (250:1 mol/mol),AAC,-0.0940454944002697,0.00990923155195835,640,pan-cancer mRNA,CTRPv2,Dasatinib,AAC,-0.100249752198469,0.0118285915894336,262,pan-cancer mRNA,FIMM,Cytarabine,AAC,0.373413415367493,0.0123179114978478,257,pan-cancer mRNA,gCSI,Doxorubicin,AAC,0.139166911344227,0.0131372827757058,273,pan-cancer mRNA,GDSC1000,XL-184,AAC,-0.0912160409044374,0.0131686016089847,740,pan-cancer mRNA,GDSC1000,AMG-706,AAC,-0.0911810233536809,0.0135586043344371,31,pan-cancer mRNA,GDSC1000,Sorafenib,AAC,-0.137540990208737,0.0136294872215573,651,pan-cancer mRNA,CTRPv2,navitoclax:pluripotin (1:1 mol/mol),AAC,-0.0953166471376694,0.0137162231260322,479,pan-cancer mRNA,GDSC1000,linifanib,AAC,-0.0925806620767793,0.0139696973667771,424,pan-cancer mRNA,CTRPv2,GSK-J4,AAC,0.236739355688301,0.0148534754292145,325,pan-cancer mRNA,CTRPv2,PIK-93,AAC,-0.0919730439769019,0.0149128929954234,561,pan-cancer mRNA,GDSC1000,17-AAG,AAC,-0.0821300429530765,0.015312891727911,3,pan-cancer mRNA,GDSC1000,BAY 61-3606,AAC,-0.0896711836773836,0.015324994264468,66,pan-cancer mRNA,FIMM,Bexarotene,AAC,-0.358846072844334,0.0155248627194032,72,pan-cancer mRNA,GDSC1000,Nutlin-3a (-),AAC,-0.0868213968246214,0.0160829716833998,508,pan-cancer mRNA,CCLE,RAF265,AAC,0.127622244270153,0.0161752617525432,590,pan-cancer mRNA,CTRPv2,avicin D,AAC,-0.138467110108878,0.0168099033727957,45,pan-cancer mRNA,GDSC1000,AC220,AAC,-0.0892319144771696,0.0168566677684611,19,pan-cancer mRNA,CTRPv2,BRD-K24690302,AAC,0.0925252456125569,0.019743995225366,119,pan-cancer mRNA,CTRPv2,carboplatin:etoposide (40:17 mol/mol),AAC,-0.073809433616111,0.021414313490499,198,pan-cancer mRNA,CTRPv2,SNX-2112:bortezomib (250:1 mol/mol),AAC,-0.0817543543829992,0.0240660822875361,650,pan-cancer mRNA,GDSC1000,SNX-2112,AAC,-0.0716275127649886,0.026744130341793,649,pan-cancer mRNA,CTRPv2,etoposide,AAC,-0.0703901741667053,0.0277178084377719,290,pan-cancer mRNA,CTRPv2,chlorambucil,AAC,-0.0745738574061959,0.0279923491631395,224,pan-cancer mRNA,CTRPv2,PI-103,AAC,-0.0830179541065464,0.0281047429352562,558,pan-cancer mRNA,CTRPv2,SB-525334,AAC,0.0869640266317338,0.0289712229445768,612,pan-cancer mRNA,GDSC1000,VNLG/124,AAC,-0.0761634915003842,0.0297332856115236,723,pan-cancer mRNA,FIMM,Doxorubicin,AAC,0.304972806513381,0.0303865295836189,273,pan-cancer mRNA,CTRPv2,parbendazole,AAC,-0.0715184121586957,0.0304197983442071,530,pan-cancer mRNA,GDSC1000,PLX4720,AAC,0.0710526523441267,0.0308643431176846,569,pan-cancer mRNA,CTRPv2,momelotinib,AAC,-0.0808830711056016,0.0315270059659305,465,pan-cancer mRNA,CTRPv2,salermide:PLX-4032 (12:1 mol/mol),AAC,0.0858339509895861,0.031573064854487,605,pan-cancer mRNA,GDSC1000,KIN001-055,AAC,-0.0785871995452948,0.0316000570283557,397,pan-cancer mRNA,GDSC1000,THZ-2-49,AAC,-0.0686975127954332,0.0317132492550282,688,pan-cancer mRNA,CCLE,paclitaxel,AAC,0.104747105076207,0.0317652372645854,526,pan-cancer mRNA,CCLE,Irinotecan,AAC,0.128758370805089,0.0319575779129732,367,pan-cancer mRNA,CTRPv2,paclitaxel,AAC,-0.0769724771723133,0.031999759927516,526,pan-cancer mRNA,CCLE,lapatinib,AAC,-0.103134714369199,0.0321007729458371,415,pan-cancer mRNA,CTRPv2,TAE684,AAC,-0.0809467633183625,0.0369359327338924,669,pan-cancer mRNA,CTRPv2,KW-2449,AAC,-0.069527126832095,0.0371804663634874,411,pan-cancer mRNA,CTRPv2,BCL-LZH-4,AAC,-0.118116252704327,0.0380375609478621,67,pan-cancer mRNA,GDSC1000,dabrafenib,AAC,0.0670824714609888,0.0381532269833149,259,pan-cancer mRNA,CTRPv2,ML312,AAC,0.162363660607117,0.0393253004473532,459,pan-cancer mRNA,CTRPv2,itraconazole,AAC,-0.0881485581839857,0.0393680067538616,376,pan-cancer mRNA,CTRPv2,KU 0060648,AAC,-0.0809473667573868,0.040135985015149,407,pan-cancer mRNA,gCSI,Vorinostat,AAC,0.11533411660298,0.0405756870084117,725,pan-cancer mRNA,GDSC1000,CHIR-99021,AAC,-0.0697626460382063,0.0406562017502256,223,pan-cancer mRNA,FIMM,MS-275,AAC,0.265404560637626,0.0407302154509606,468,pan-cancer mRNA,GDSC1000,Gefitinib,AAC,-0.0713168539153696,0.0417089808205116,314,pan-cancer mRNA,gCSI,Bortezomib,AAC,0.13268816419711,0.0418512816306369,92,pan-cancer mRNA,CTRPv2,ISOX,AAC,0.0697773430692803,0.0423412909359915,371,pan-cancer mRNA,GDSC1000,Bosutinib,AAC,0.0722903185512976,0.0426062170986649,93,pan-cancer mRNA,GDSC1000,SL 0101-1,AAC,-0.0767519690296464,0.0433910920220435,645,pan-cancer mRNA,GDSC1000,CCT018159,AAC,-0.073547512975823,0.0451642811579706,206,pan-cancer mRNA,CTRPv2,BRD-K63431240,AAC,-0.077132823745608,0.0454237162899471,153,pan-cancer mRNA,CTRPv2,AZD0530,AAC,-0.0804540392117776,0.046610524876234,53,pan-cancer mRNA,CTRPv2,neratinib,AAC,-0.0777662059550388,0.0466156418769303,488,pan-cancer mRNA,GDSC1000,PD-0332991,AAC,-0.0719646344227864,0.0477414801708054,536,pan-cancer mRNA,CTRPv2,EX-527,AAC,0.0844505068668093,0.048606357286871,293,pan-cancer mRNA,CTRPv2,importazole,AAC,-0.0854886333161675,0.0493869413379497,362,pan-cancer mRNA,CTRPv2,serdemetan:SCH-529074 (1:1 mol/mol),AAC,0.075214310292116,0.0496372151973332,631,pan-cancer mRNA,CTRPv2,tipifarnib,AAC,-0.0674003483893895,0.0502261696052174,690,pan-cancer mRNA,CTRPv2,B02,AAC,-0.078623428108947,0.0502973482800524,60,pan-cancer mRNA,CTRPv2,SID 26681509,AAC,-0.0826036370205392,0.0512935690770641,635,pan-cancer mRNA,GDSC1000,OSI-930,AAC,-0.0722586204453483,0.0515329839460965,520,pan-cancer mRNA,CTRPv2,KU-0063794,AAC,-0.0746341121520965,0.0516853727566287,408,pan-cancer mRNA,CTRPv2,foretinib,AAC,-0.0747773590695627,0.0518703137960471,301,pan-cancer mRNA,CTRPv2,Bortezomib,AAC,-0.0733217829658687,0.0522340367068731,92,pan-cancer mRNA,CTRPv2,BRD9876:MK-1775 (4:1 mol/mol),AAC,-0.205781491298247,0.0524733773415381,185,pan-cancer mRNA,CTRPv2,BRD-K26531177,AAC,-0.079382687008286,0.0536009105565842,120,pan-cancer mRNA,CTRPv2,PF-184,AAC,-0.0703525414691572,0.0541127400690327,542,pan-cancer mRNA,GDSC1000,Vorinostat,AAC,0.0634527353130722,0.0541410941039607,725,pan-cancer mRNA,CTRPv2,linifanib,AAC,-0.0741651003168913,0.0555002008718154,424,pan-cancer mRNA,CTRPv2,BRD-K71781559,AAC,0.0789630054141689,0.0570223033313512,158,pan-cancer mRNA,CTRPv2,HLI 373,AAC,-0.07547321391062,0.0573195799262789,351,pan-cancer mRNA,CTRPv2,BRD-K61166597,AAC,0.0667645954447783,0.0573718177853056,152,pan-cancer mRNA,gCSI,MS-275,AAC,0.110127646159323,0.0579776930509598,468,pan-cancer mRNA,CTRPv2,prochlorperazine,AAC,0.0772988796087051,0.058506564453769,574,pan-cancer mRNA,CTRPv2,docetaxel:tanespimycin (2:1 mol/mol),AAC,-0.0659405029753034,0.0595538469931062,272,pan-cancer mRNA,gCSI,Gemcitabine,AAC,0.113975559830405,0.0597324265451176,316,pan-cancer mRNA,CTRPv2,BRD-K34485477,AAC,0.147363728706169,0.0601124478356378,134,pan-cancer mRNA,CTRPv2,BRD-K85133207,AAC,0.0769405197517043,0.0611307314667931,165,pan-cancer mRNA,CTRPv2,BRD-K03911514,AAC,0.115368106781538,0.0611747849155904,105,pan-cancer mRNA,CTRPv2,GSK461364,AAC,-0.0639794555886339,0.061372920577957,338,pan-cancer mRNA,GDSC1000,Erlotinib,AAC,-0.0930060211885811,0.0615461282171034,287,pan-cancer mRNA,CTRPv2,Rapamycin,AAC,-0.0685960183733832,0.0634279788911334,591,pan-cancer mRNA,CTRPv2,BRD-K45681478,AAC,0.0728005727547433,0.0638023556524123,141,pan-cancer mRNA,CTRPv2,AT7867,AAC,-0.0718250312435447,0.06383004299561,41,pan-cancer mRNA,GDSC1000,Midostaurin,AAC,-0.0689440464803743,0.0643598419866106,444,pan-cancer mRNA,CTRPv2,BRD-K51831558,AAC,0.101273640346493,0.0648363146899958,147,pan-cancer mRNA,CTRPv2,CCT036477,AAC,-0.0675800755353172,0.0669515158232496,207,pan-cancer mRNA,CTRPv2,5-FU,AAC,-0.0673010037446892,0.0675341004107755,7,pan-cancer mRNA,CTRPv2,KPT185,AAC,-0.0750148562129895,0.0677492458167198,406,pan-cancer mRNA,CTRPv2,BRD-K64610608,AAC,-0.0765091978882796,0.0688208642485872,154,pan-cancer mRNA,FIMM,Tipifarnib,AAC,0.231012127352353,0.0693882268819331,691,pan-cancer mRNA,CTRPv2,Imatinib,AAC,-0.0710342996715149,0.0694137440925316,361,pan-cancer mRNA,CTRPv2,MK-2206,AAC,-0.0707582049546885,0.0705574116049132,448,pan-cancer mRNA,GDSC1000,AKT inhibitor VIII,AAC,-0.0667051334017834,0.0717324538745036,26,pan-cancer mRNA,CTRPv2,tanespimycin:bortezomib (250:1 mol/mol),AAC,-0.0720763044566547,0.0754426102823375,675,pan-cancer mRNA,GDSC1000,GDC-0449,AAC,-0.0678119627774048,0.0759175732896714,311,pan-cancer mRNA,CTRPv2,Zebularine,AAC,-0.065470099860587,0.0766032275846689,755,pan-cancer mRNA,gCSI,Crizotinib,AAC,0.109748020553722,0.0770071370221005,248,pan-cancer mRNA,CTRPv2,pac-1,AAC,0.0681265439406425,0.0788041642635746,525,pan-cancer mRNA,GDSC1000,MG-132,AAC,0.0888866046739412,0.0803275168849658,440,pan-cancer mRNA,GDSC1000,foretinib,AAC,-0.0611589373285224,0.0808347685815477,301,pan-cancer mRNA,CCLE,Panobinostat,AAC,0.0777107279806829,0.0811675261065809,529,pan-cancer mRNA,GDSC1000,AT-7519,AAC,-0.0554309024262453,0.0820064022098567,39,pan-cancer mRNA,GDSC1000,TG-101348,AAC,-0.0532380762328518,0.0820179872543681,683,pan-cancer mRNA,CTRPv2,NVP-BEZ235,AAC,-0.0788283024963308,0.0824875862792721,511,pan-cancer mRNA,GDSC1000,I-BET-762,AAC,-0.0514014022313871,0.0825489073869964,353,pan-cancer mRNA,CTRPv2,tamatinib,AAC,-0.0717444951695725,0.0826961072044428,672,pan-cancer mRNA,GDSC1000,FTI-277,AAC,-0.0632356813490562,0.0834067038193631,307,pan-cancer mRNA,CTRPv2,staurosporine,AAC,-0.132925400971436,0.0836214046795286,658,pan-cancer mRNA,GDSC1000,Roscovitine,AAC,-0.0933367503767585,0.0838084649859035,600,pan-cancer mRNA,CTRPv2,Ki8751,AAC,-0.0687326648679715,0.0839163914736583,396,pan-cancer mRNA,CTRPv2,Axitinib,AAC,-0.0652048147495836,0.0841897125604759,47,pan-cancer mRNA,CTRPv2,AZD8055,AAC,-0.0651514211812789,0.0869848326801317,59,pan-cancer mRNA,CTRPv2,PF-573228,AAC,-0.0638473730511903,0.0888594128883625,551,pan-cancer mRNA,CTRPv2,tretinoin:carboplatin (2:1 mol/mol),AAC,-0.0643771589991423,0.0890075599364401,700,pan-cancer mRNA,FIMM,Topotecan,AAC,0.177536966118591,0.0891973363608,697,pan-cancer mRNA,gCSI,Docetaxel,AAC,0.09990848609812,0.089243902275129,271,pan-cancer mRNA,GDSC1000,LY317615,AAC,-0.0623990375637292,0.0896370748286179,431,pan-cancer mRNA,GDSC1000,AS601245,AAC,-0.06365932917064,0.089706755423942,36,pan-cancer mRNA,CTRPv2,cabozantinib,AAC,-0.0668930543669537,0.0898875081225418,193,pan-cancer mRNA,GDSC1000,SB52334,AAC,0.060468087720269,0.0911202128440987,614,pan-cancer mRNA,UHNBreast,AZD6244,AAC,0.487199297374808,0.0912903849478856,56,pan-cancer mRNA,CTRPv2,SCH-79797,AAC,0.0662941084274221,0.0928601370538373,617,pan-cancer mRNA,CTRPv2,BI-2536,AAC,-0.0572216990558913,0.0929779349649558,74,pan-cancer mRNA,CTRPv2,BRD9876,AAC,-0.0706687827998455,0.0934126560312051,184,pan-cancer mRNA,CTRPv2,doxorubicin:navitoclax (2:1 mol/mol),AAC,-0.05777917134486,0.0963332526015943,274,pan-cancer mRNA,CTRPv2,WZ4002,AAC,-0.0806952794366358,0.0964358100056916,737,pan-cancer mRNA,FIMM,Erlotinib,AAC,0.272751066807813,0.0973642542624191,287,pan-cancer mRNA,CTRPv2,BRD-K01737880,AAC,-0.182187186653869,0.097438797353012,101,pan-cancer mRNA,CTRPv2,salermide,AAC,-0.0837206943136304,0.0983634270404407,604,pan-cancer mRNA,CTRPv2,GSK4112,AAC,-0.0669468303491535,0.0990259673191359,336,pan-cancer mRNA,GDSC1000,JQ-1,AAC,-0.0578709524198161,0.0997645892086233,382,pan-cancer mRNA,CTRPv2,VX-680,AAC,-0.164475759045852,0.0997699625252281,730,pan-cancer mRNA,CTRPv2,BRD-K80183349,AAC,0.0579605305964238,0.100529048694034,163,pan-cancer mRNA,gCSI,paclitaxel,AAC,0.0948694087361301,0.101205174078598,526,pan-cancer mRNA,CTRPv2,BRD-K27986637,AAC,0.123223471308373,0.102426915546714,124,pan-cancer mRNA,GDSC1000,JNK Inhibitor VIII,AAC,-0.0592110791557528,0.105130316137321,380,pan-cancer mRNA,CTRPv2,Sildenafil,AAC,-0.0689895966649614,0.105774514842816,637,pan-cancer mRNA,CTRPv2,BRD-K11533227,AAC,0.0663746417648951,0.110379582498722,110,pan-cancer mRNA,CTRPv2,Crizotinib,AAC,-0.0561035825797404,0.110915931231252,248,pan-cancer mRNA,CTRPv2,silmitasertib,AAC,-0.0654265098810241,0.111644992339701,638,pan-cancer mRNA,CTRPv2,SB-743921,AAC,-0.0555105590352409,0.114213784910991,613,pan-cancer mRNA,CTRPv2,BRD-K75293299,AAC,-0.120640307064725,0.115839013589132,160,pan-cancer mRNA,CTRPv2,NPC-26,AAC,-0.066064322101894,0.115898993033373,493,pan-cancer mRNA,gCSI,Rapamycin,AAC,0.0946243853464682,0.116118339540744,591,pan-cancer mRNA,GDSC1000,AUY922,AAC,-0.0590360079248328,0.116136566591582,44,pan-cancer mRNA,CTRPv2,fingolimod,AAC,-0.0617182608979953,0.116317512277566,297,pan-cancer mRNA,CTRPv2,Topotecan,AAC,-0.0548480797053633,0.118031602673317,697,pan-cancer mRNA,CTRPv2,SGX-523,AAC,-0.0635724786366308,0.121553723935885,633,pan-cancer mRNA,CTRPv2,BIBW2992,AAC,-0.0610956763093894,0.121991087774217,76,pan-cancer mRNA,CTRPv2,Nilotinib,AAC,-0.0636084124884686,0.122232742643733,491,pan-cancer mRNA,GDSC1000,Parthenolide,AAC,0.083943845941089,0.123008873918688,531,pan-cancer mRNA,GDSC1000,WZ-1-84,AAC,-0.081215655457721,0.123050905006849,735,pan-cancer mRNA,CTRPv2,betulinic acid,AAC,-0.0653490492717423,0.125150495367245,71,pan-cancer mRNA,GDSC1000,rTRAIL,AAC,-0.0577508166725132,0.1256108638652,601,pan-cancer mRNA,CTRPv2,KH-CB19,AAC,0.0765304180403107,0.127149343070005,394,pan-cancer mRNA,CTRPv2,TPCA-1,AAC,-0.0543563067846586,0.127753983114146,699,pan-cancer mRNA,CTRPv2,RAF265,AAC,0.0639264524334037,0.129556977878355,590,pan-cancer mRNA,CTRPv2,BRD-K88742110,AAC,0.0603252789502086,0.130167171314394,167,pan-cancer mRNA,CTRPv2,tandutinib,AAC,-0.0604834119629742,0.130737284631075,674,pan-cancer mRNA,CTRPv2,elocalcitol,AAC,-0.0581497995339273,0.131863640365515,279,pan-cancer mRNA,GDSC1000,HG-6-64-1,AAC,-0.0550513054432755,0.132462805586275,350,pan-cancer mRNA,CTRPv2,BRD-K02492147,AAC,0.0678777205611675,0.132731873200045,103,pan-cancer mRNA,CTRPv2,ibrutinib,AAC,-0.0678833710925894,0.13274189283224,356,pan-cancer mRNA,GDSC1000,Pazopanib,AAC,-0.0549283718193043,0.136596184290115,533,pan-cancer mRNA,CTRPv2,Merck60,AAC,0.0492588136893563,0.137262548194437,437,pan-cancer mRNA,CTRPv2,BRD-K29313308,AAC,0.0604526124845745,0.13800165834549,127,pan-cancer mRNA,GDSC1000,KIN001-135,AAC,-0.0833094081002731,0.13859910662849,399,pan-cancer mRNA,GDSC1000,etoposide,AAC,0.055785252452731,0.13871377956675,290,pan-cancer mRNA,GDSC1000,RO-3306,AAC,-0.0543678602569422,0.138838109519636,598,pan-cancer mRNA,CTRPv2,BRD-K96970199,AAC,-0.118475448565231,0.14344794122779,172,pan-cancer mRNA,CTRPv2,ZSTK474,AAC,-0.0597304529922673,0.145853708395415,759,pan-cancer mRNA,FIMM,Methotrexate,AAC,0.191434426989894,0.146726032821528,438,pan-cancer mRNA,CTRPv2,3-Cl-AHPC,AAC,-0.05448931160118,0.146968999496849,5,pan-cancer mRNA,CTRPv2,lovastatin,AAC,-0.057770913326383,0.1470266194867,427,pan-cancer mRNA,CTRPv2,MI-2,AAC,0.0820198567914462,0.147712925776987,443,pan-cancer mRNA,CTRPv2,BRD-K35604418,AAC,-0.0577235752741282,0.149542698926148,135,pan-cancer mRNA,GDSC1000,KU-55933,AAC,-0.054019154575053,0.150043946052175,409,pan-cancer mRNA,CTRPv2,BRD-K90370028,AAC,-0.0851735450046239,0.150220770306235,168,pan-cancer mRNA,CTRPv2,ML334 diastereomer,AAC,0.069349497312588,0.151301392161287,461,pan-cancer mRNA,CTRPv2,PF-4800567 hydrochloride,AAC,-0.0829920438615849,0.152807647595106,548,pan-cancer mRNA,GDSC1000,ATRA,AAC,-0.0517713186630992,0.153311501466558,42,pan-cancer mRNA,CTRPv2,alisertib,AAC,-0.0494918052857326,0.155986948577266,27,pan-cancer mRNA,CTRPv2,AZD6482,AAC,-0.0558735265589103,0.156948738531777,57,pan-cancer mRNA,GDSC1000,XMD13-2,AAC,0.0478065617609961,0.157201818055534,743,pan-cancer mRNA,GDSC1000,MS-275,AAC,0.0747855232433568,0.157925406769468,468,pan-cancer mRNA,CTRPv2,ML239,AAC,-0.0557742855636317,0.158124224986217,456,pan-cancer mRNA,CTRPv2,myricetin,AAC,-0.0588688532858831,0.162198658382585,470,pan-cancer mRNA,CTRPv2,BRD-K17060750,AAC,0.0583584723242289,0.16272632682151,116,pan-cancer mRNA,FIMM,AZD-2281,AAC,0.230860083622307,0.163145140787223,51,pan-cancer mRNA,CTRPv2,indisulam,AAC,-0.0480004623809436,0.164196532669726,363,pan-cancer mRNA,CCLE,Topotecan,AAC,0.0642779252111835,0.165506454082164,697,pan-cancer mRNA,CTRPv2,hyperforin,AAC,-0.0600320853778262,0.167027366552518,352,pan-cancer mRNA,CTRPv2,WZ8040,AAC,-0.058480450719211,0.170996949312757,738,pan-cancer mRNA,CTRPv2,tanespimycin:gemcitabine (1:1 mol/mol),AAC,-0.0489804051705171,0.17101391303853,676,pan-cancer mRNA,CCLE,L-685458,AAC,0.0672826108180183,0.172462845535894,413,pan-cancer mRNA,CTRPv2,KX2-391,AAC,-0.047375579831298,0.172900270771477,412,pan-cancer mRNA,CTRPv2,CBB-1007,AAC,0.0788624067848776,0.173972052235649,204,pan-cancer mRNA,CTRPv2,fulvestrant,AAC,-0.113235279845686,0.176051882393057,308,pan-cancer mRNA,CTRPv2,Nutlin-3,AAC,-0.0510468639145357,0.181479930925196,507,pan-cancer mRNA,CTRPv2,MLN2238,AAC,0.0505008639059177,0.182091499334417,462,pan-cancer mRNA,GDSC1000,TW 37,AAC,0.0471992404337271,0.182111061201922,708,pan-cancer mRNA,FIMM,Irinotecan,AAC,0.150072994821848,0.185865011009953,367,pan-cancer mRNA,GDSC1000,Ispinesib Mesylate,AAC,-0.0453377763763488,0.187176067498663,374,pan-cancer mRNA,CTRPv2,OSI-906,AAC,-0.0505568683785628,0.187640099734554,519,pan-cancer mRNA,CTRPv2,AM-580,AAC,-0.0535942364816438,0.191522161597825,30,pan-cancer mRNA,GDSC1000,XMD8-92,AAC,0.0641128188954951,0.193245177789951,747,pan-cancer mRNA,CTRPv2,navitoclax:piperlongumine (1:1 mol/mol),AAC,-0.0497139340710235,0.194036278586428,478,pan-cancer mRNA,GDSC1000,GSK690693,AAC,0.0446616212114251,0.196058514254607,340,pan-cancer mRNA,CCLE,17-AAG,AAC,-0.0650944033625159,0.19705857606301,3,pan-cancer mRNA,CTRPv2,regorafenib,AAC,-0.0534717798943016,0.197300137436988,593,pan-cancer mRNA,CTRPv2,avrainvillamide,AAC,-0.0590601725293234,0.198116649165938,46,pan-cancer mRNA,CTRPv2,NVP-BSK805,AAC,-0.0471294853625068,0.199106232565544,512,pan-cancer mRNA,CTRPv2,SB-225002,AAC,-0.0428210764470553,0.200017127258527,609,pan-cancer mRNA,GDSC1000,Sunitinib,AAC,-0.0673885453084468,0.200694542120429,663,pan-cancer mRNA,GDSC1000,GW 441756,AAC,0.0481324528292475,0.201864990189349,342,pan-cancer mRNA,CTRPv2,nakiterpiosin,AAC,-0.0456567979994806,0.202462187638515,473,pan-cancer mRNA,GDSC1000,JNK-9L,AAC,-0.0478915696097107,0.205547010164427,381,pan-cancer mRNA,CTRPv2,alisertib:navitoclax (2:1 mol/mol),AAC,-0.0492552113103314,0.206069469944083,28,pan-cancer mRNA,CTRPv2,BRD-K51490254,AAC,0.0528729483082714,0.206309589818193,146,pan-cancer mRNA,GDSC1000,NU-7441,AAC,-0.0478481941283665,0.209104597564459,505,pan-cancer mRNA,GDSC1000,WZ3105,AAC,0.0402814381212104,0.210656956416528,736,pan-cancer mRNA,gCSI,PD-0325901,AAC,0.0698051313944413,0.212330057040638,535,pan-cancer mRNA,CCLE,AEW541,AAC,-0.0622527664295109,0.212648445394161,21,pan-cancer mRNA,CTRPv2,BIX-01294,AAC,0.0463566157930689,0.213188797946481,81,pan-cancer mRNA,GDSC1000,Obatoclax Mesylate,AAC,0.0460041480512184,0.213280658417102,514,pan-cancer mRNA,CTRPv2,SCH-529074,AAC,0.0523149613629253,0.215102036246139,616,pan-cancer mRNA,CTRPv2,FQI-2,AAC,-0.0430385753690605,0.215182521451604,303,pan-cancer mRNA,CTRPv2,COL-3,AAC,0.0514554159815481,0.215392785917755,240,pan-cancer mRNA,GDSC1000,AICAR,AAC,-0.0420140938217622,0.216795351290058,25,pan-cancer mRNA,CTRPv2,TG-100-115,AAC,0.0492373861637976,0.216922382194856,682,pan-cancer mRNA,FIMM,S-Trityl-L-cysteine,AAC,-0.219990201910691,0.217315566319804,603,pan-cancer mRNA,GDSC1000,BMS-754807,AAC,-0.0439337170553686,0.22572437923688,91,pan-cancer mRNA,GDSC1000,Bicalutamide,AAC,-0.0436233345500988,0.226378007145755,77,pan-cancer mRNA,CTRPv2,MS-275,AAC,0.041970249506552,0.229930448888376,468,pan-cancer mRNA,CTRPv2,JQ-1,AAC,-0.0405163261476657,0.230651532484693,382,pan-cancer mRNA,GDSC1000,BMS-708163,AAC,-0.0433081802854679,0.231154978477824,90,pan-cancer mRNA,GDSC1000,KIN001-260,AAC,-0.0404056439863289,0.231483961303459,402,pan-cancer mRNA,CTRPv2,JW-74,AAC,-0.0589888444710031,0.232942144599321,393,pan-cancer mRNA,GDSC1000,NPK76-II-72-1,AAC,0.0378337357619776,0.233040640397367,494,pan-cancer mRNA,CTRPv2,Teniposide,AAC,-0.0539529061867961,0.234587453853848,681,pan-cancer mRNA,GDSC1000,Bortezomib,AAC,0.0602251302502609,0.23560969208725,92,pan-cancer mRNA,CTRPv2,CAY10618,AAC,0.0457285610006615,0.235913761655056,203,pan-cancer mRNA,CTRPv2,istradefylline,AAC,0.0698766864877433,0.237030153133414,375,pan-cancer mRNA,GDSC1000,Pyrimethamine,AAC,0.0643078080896643,0.23705276364957,580,pan-cancer mRNA,CTRPv2,JQ-1:navitoclax (2:1 mol/mol),AAC,-0.0434184953256298,0.237718022541605,385,pan-cancer mRNA,CTRPv2,myriocin,AAC,0.096017574983886,0.238101646892671,471,pan-cancer mRNA,CTRPv2,SZ4TA2,AAC,0.0664402497596057,0.238826774574974,665,pan-cancer mRNA,GDSC1000,CGP-60474,AAC,-0.0622884147930284,0.240213405925796,218,pan-cancer mRNA,GDSC1000,LFM-A13,AAC,-0.0439534989911322,0.240370412850661,423,pan-cancer mRNA,CTRPv2,Doxorubicin,AAC,-0.0380191109200557,0.240412397577826,273,pan-cancer mRNA,CTRPv2,SR8278,AAC,0.137844765907761,0.241127557647022,656,pan-cancer mRNA,GDSC1000,(5Z)-7-Oxozeaenol,AAC,0.0388863148287437,0.241302056116824,1,pan-cancer mRNA,CTRPv2,Mitomycin-C,AAC,-0.0420649958980575,0.242309009856089,445,pan-cancer mRNA,CTRPv2,piperlongumine:MST-312 (1:1 mol/mol),AAC,-0.0454143211413126,0.247492699340021,563,pan-cancer mRNA,CTRPv2,ATRA,AAC,-0.0431254150374557,0.250395600787604,42,pan-cancer mRNA,CTRPv2,NVP-ADW742,AAC,-0.0430997483425379,0.251936083048391,510,pan-cancer mRNA,CTRPv2,tivozanib,AAC,-0.0456260620129141,0.252092216831002,693,pan-cancer mRNA,CTRPv2,tosedostat,AAC,-0.0462428949329918,0.252174577913032,698,pan-cancer mRNA,GDSC1000,CAL-101,AAC,-0.039016661605289,0.252212486742733,194,pan-cancer mRNA,CTRPv2,MK 1775,AAC,-0.0419103051099026,0.252473576126336,446,pan-cancer mRNA,GDSC1000,CP724714,AAC,-0.0416271605609822,0.252666122201467,246,pan-cancer mRNA,GDSC1000,Epothilone B,AAC,-0.0427790686736575,0.25356069834667,283,pan-cancer mRNA,CTRPv2,GSK1120212,AAC,0.0577833078311501,0.253785320437184,329,pan-cancer mRNA,CTRPv2,Compound 1541A,AAC,-0.0491575325322937,0.255654875744268,241,pan-cancer mRNA,GDSC1000,FH535,AAC,0.0419787985574015,0.256458380350825,296,pan-cancer mRNA,CTRPv2,IU1,AAC,-0.0480971685730928,0.257007674171103,377,pan-cancer mRNA,CTRPv2,CAL-101,AAC,-0.044620063704177,0.260160598021438,194,pan-cancer mRNA,FIMM,temsirolimus,AAC,0.180718553944191,0.260444363782755,680,pan-cancer mRNA,CTRPv2,BRD-K20514654,AAC,-0.0643145649932344,0.260564196729882,118,pan-cancer mRNA,CTRPv2,CIL56,AAC,-0.0593728544936365,0.261298808097319,234,pan-cancer mRNA,GDSC1000,temsirolimus,AAC,0.0405064603646979,0.261639263483178,680,pan-cancer mRNA,GDSC1000,Tamoxifen,AAC,-0.0411791162769675,0.261710717657564,673,pan-cancer mRNA,GDSC1000,BI-2536,AAC,0.0602535406582902,0.261880050327281,74,pan-cancer mRNA,CTRPv2,Methotrexate,AAC,0.0444661527941174,0.262673486579519,438,pan-cancer mRNA,GDSC1000,PF-562271,AAC,-0.0408553972744911,0.262709803159662,550,pan-cancer mRNA,CTRPv2,selumetinib:vorinostat (8:1 mol/mol),AAC,0.0437269156839368,0.264844273716645,628,pan-cancer mRNA,CTRPv2,CIL55,AAC,-0.0772343969181619,0.267344983435959,232,pan-cancer mRNA,CTRPv2,etomoxir,AAC,0.045473572679596,0.26976234595379,289,pan-cancer mRNA,GDSC1000,UNC0638,AAC,0.0348053308302613,0.275910635178496,711,pan-cancer mRNA,GDSC1000,thapsigargin,AAC,-0.0411129805471011,0.276555564601297,686,pan-cancer mRNA,CTRPv2,AZD1480,AAC,-0.062268030970936,0.276640666765126,54,pan-cancer mRNA,FIMM,Gefitinib,AAC,0.174379287252098,0.277633274032864,314,pan-cancer mRNA,CTRPv2,BRD-K27188169:navitoclax (2:1 mol/mol),AAC,-0.0655217167711084,0.278515644984046,122,pan-cancer mRNA,gCSI,thapsigargin,AAC,0.0667900620012637,0.280586233807117,686,pan-cancer mRNA,CTRPv2,GSK2636771,AAC,-0.0501347673036144,0.282312095128835,334,pan-cancer mRNA,CTRPv2,decitabine:navitoclax (2:1 mol/mol),AAC,-0.03626267480124,0.283619688798883,266,pan-cancer mRNA,CTRPv2,blebbistatin,AAC,-0.0821463323887489,0.283982747655801,83,pan-cancer mRNA,GDSC1000,GW-2580,AAC,0.0402671279895458,0.284226435722914,343,pan-cancer mRNA,CTRPv2,BRD-K30748066,AAC,0.118315563071146,0.285566591488343,129,pan-cancer mRNA,CTRPv2,JW-55,AAC,-0.0957093168469439,0.289338442643876,390,pan-cancer mRNA,CTRPv2,Oxaliplatin,AAC,-0.0384535899902707,0.29029342087764,523,pan-cancer mRNA,CTRPv2,BRD-A02303741,AAC,0.0458462998450991,0.290366546596341,94,pan-cancer mRNA,CTRPv2,vincristine,AAC,-0.0346800606561194,0.290988496653615,721,pan-cancer mRNA,CTRPv2,BRD-K66532283,AAC,0.0380957433893382,0.291875636531694,156,pan-cancer mRNA,GDSC1000,GSK269962A,AAC,-0.0365597088587371,0.293398655536572,335,pan-cancer mRNA,CCLE,Erlotinib,AAC,-0.0517180993174385,0.295401370135565,287,pan-cancer mRNA,GDSC1000,PHA-665752,AAC,-0.0553784006089534,0.301397877357898,554,pan-cancer mRNA,CTRPv2,BRD-A94377914,AAC,-0.0510334136703556,0.301529731539287,100,pan-cancer mRNA,GDSC1000,PHA-793887,AAC,-0.0317426218040065,0.302816229874519,555,pan-cancer mRNA,GDSC1000,Elesclomol,AAC,0.0374143283046447,0.303542105421564,278,pan-cancer mRNA,CTRPv2,Tamoxifen,AAC,-0.0429653665395324,0.304320396670012,673,pan-cancer mRNA,FIMM,Bicalutamide,AAC,-0.173569792372534,0.30451481585532,77,pan-cancer mRNA,GDSC1000,Zibotentan,AAC,0.0370420352536751,0.306394714629201,757,pan-cancer mRNA,CTRPv2,LRRK2-IN-1,AAC,-0.0404750885278928,0.306411807019498,428,pan-cancer mRNA,CTRPv2,Fumonisin B1,AAC,-0.0410116384767795,0.307266623064037,309,pan-cancer mRNA,CTRPv2,selumetinib:JQ-1 (4:1 mol/mol),AAC,-0.0377896357662799,0.307596493166821,621,pan-cancer mRNA,CTRPv2,necrostatin-1,AAC,0.0416882805342346,0.308595996481503,482,pan-cancer mRNA,CTRPv2,BRD-K33514849,AAC,-0.121316285745769,0.308950552014772,131,pan-cancer mRNA,CTRPv2,BRD-K44224150,AAC,0.0797924534500313,0.309631204409986,140,pan-cancer mRNA,CTRPv2,quizartinib,AAC,-0.0420280559773049,0.309764063142036,587,pan-cancer mRNA,CTRPv2,BRD-K41334119,AAC,0.0771112388035856,0.310038634721587,137,pan-cancer mRNA,CTRPv2,JQ-1:UNC0638 (2:1 mol/mol),AAC,-0.0377150141052837,0.314606566523703,386,pan-cancer mRNA,CTRPv2,SKI-II,AAC,-0.0408581472691416,0.316332600314319,644,pan-cancer mRNA,CTRPv2,selumetinib:PLX-4032 (8:1 mol/mol),AAC,0.0377790147702049,0.316691981180967,625,pan-cancer mRNA,GDSC1000,SGC0946,AAC,-0.0376861717531674,0.320830626941482,632,pan-cancer mRNA,CTRPv2,BRD-K34222889,AAC,-0.0334759031449687,0.324209920281796,133,pan-cancer mRNA,CTRPv2,BRD-K27224038,AAC,-0.0747465072222269,0.324213128776612,123,pan-cancer mRNA,FIMM,Cyclopamine,AAC,-0.145512625987404,0.325522273531196,255,pan-cancer mRNA,CTRPv2,DBeQ,AAC,-0.039117720207259,0.326349206784428,263,pan-cancer mRNA,CTRPv2,BRD4132,AAC,-0.0409434662977928,0.32713022408023,179,pan-cancer mRNA,GDSC1000,QL-XII-47,AAC,-0.0345229023874112,0.328260932934629,584,pan-cancer mRNA,CTRPv2,ABT-199,AAC,-0.0470838625455593,0.329194590548647,15,pan-cancer mRNA,GDSC1000,ZG-10,AAC,0.0456708615968988,0.331251382645751,756,pan-cancer mRNA,GDSC1000,PFI-1,AAC,-0.0347038042958888,0.332657653294166,553,pan-cancer mRNA,CTRPv2,NSC632839,AAC,-0.0362310419074075,0.333468543749778,502,pan-cancer mRNA,CTRPv2,Gemcitabine,AAC,-0.0333635619299793,0.335354605754864,316,pan-cancer mRNA,FIMM,Dasatinib,AAC,-0.156998606655102,0.336248790076555,262,pan-cancer mRNA,CTRPv2,968,AAC,-0.0733402461999062,0.337227789035471,9,pan-cancer mRNA,CTRPv2,WP1130,AAC,-0.0365689280457592,0.337442004204977,734,pan-cancer mRNA,GDSC1000,EKB-569,AAC,-0.0339214032546402,0.338582479038719,276,pan-cancer mRNA,GDSC1000,Methotrexate,AAC,-0.0299556540961787,0.340417463998423,438,pan-cancer mRNA,CTRPv2,pifithrin-mu,AAC,0.0366624092776379,0.340480000912529,560,pan-cancer mRNA,CTRPv2,decitabine,AAC,-0.028705276155788,0.341063542761868,264,pan-cancer mRNA,GDSC1000,BMS-509744,AAC,0.0508293590608349,0.342818000356014,88,pan-cancer mRNA,GDSC1000,BX-795,AAC,-0.0343047631487129,0.343222429035245,189,pan-cancer mRNA,CTRPv2,FSC231,AAC,0.0700591858674366,0.344513382198595,305,pan-cancer mRNA,GDSC1000,MLN4924,AAC,0.0396964205164378,0.3463837657666,464,pan-cancer mRNA,CTRPv2,JW-480,AAC,0.0390889076678293,0.34899743223876,389,pan-cancer mRNA,CTRPv2,SN-38,AAC,-0.0371597449465052,0.349467732697136,647,pan-cancer mRNA,CTRPv2,phloretin,AAC,0.0355251136111236,0.349719828515799,557,pan-cancer mRNA,CTRPv2,nelarabine,AAC,0.0386285406676752,0.354779884428507,485,pan-cancer mRNA,FIMM,ABT-263,AAC,0.13599696502964,0.356811217234459,16,pan-cancer mRNA,CTRPv2,CI-976,AAC,-0.0400393648043653,0.357261970451875,227,pan-cancer mRNA,CTRPv2,Compound 7d-cis,AAC,-0.0358797598222381,0.35933189533183,244,pan-cancer mRNA,CTRPv2,sotrastaurin,AAC,0.0403158065611151,0.362941752460553,652,pan-cancer mRNA,GDSC1000,SB 216763,AAC,-0.0364986734176739,0.363361625607695,607,pan-cancer mRNA,GDSC1000,PD173074,AAC,-0.0338036769552677,0.365595789700674,537,pan-cancer mRNA,CTRPv2,selumetinib:piperlongumine (8:1 mol/mol),AAC,0.0348072612055282,0.365739811428101,624,pan-cancer mRNA,CTRPv2,Vandetanib,AAC,-0.0352326585703417,0.366943220496677,717,pan-cancer mRNA,GDSC1000,NSC-207895,AAC,0.0324733316011654,0.368703790395713,496,pan-cancer mRNA,CTRPv2,PL-DI,AAC,-0.0314681564505127,0.369258271201379,565,pan-cancer mRNA,CTRPv2,JQ-1:vorinostat (2:1 mol/mol),AAC,-0.0319740521051413,0.372415136796225,387,pan-cancer mRNA,CTRPv2,tacrolimus,AAC,-0.03520707123855,0.372452598502243,668,pan-cancer mRNA,CTRPv2,BRD-K78574327,AAC,-0.0687639546678575,0.374647552520982,161,pan-cancer mRNA,GDSC1000,BMS-536924,AAC,-0.0308827196992761,0.376931303905662,89,pan-cancer mRNA,CTRPv2,masitinib,AAC,-0.0355706561117832,0.378531494845881,434,pan-cancer mRNA,CTRPv2,BRD1812,AAC,-0.0341662207699289,0.378724193453018,177,pan-cancer mRNA,CTRPv2,BRD-A05715709,AAC,-0.0530723199668756,0.379096911309649,97,pan-cancer mRNA,GDSC1000,GNF-2,AAC,0.0473632149601276,0.381109341705753,320,pan-cancer mRNA,GDSC1000,AP-24534,AAC,-0.0314419123352978,0.382075137112828,32,pan-cancer mRNA,CTRPv2,CIL41,AAC,0.0509284509138173,0.383537674010765,231,pan-cancer mRNA,CTRPv2,BMS-195614,AAC,0.0368128360081226,0.38362044272156,85,pan-cancer mRNA,CTRPv2,MGCD-265,AAC,-0.0324120611654186,0.384456627786976,441,pan-cancer mRNA,CTRPv2,GSK1059615,AAC,-0.0422784919701223,0.385017985864478,326,pan-cancer mRNA,CTRPv2,navitoclax:PLX-4032 (1:1 mol/mol),AAC,0.0328473101962021,0.389219084657072,480,pan-cancer mRNA,CTRPv2,birinapant,AAC,0.0349520781165769,0.390196954564623,80,pan-cancer mRNA,CTRPv2,navitoclax:MST-312 (1:1 mol/mol),AAC,-0.0336314412665227,0.391303625141621,477,pan-cancer mRNA,CTRPv2,JNJ-26854165,AAC,-0.0314397536873041,0.391504860351929,379,pan-cancer mRNA,CTRPv2,GSK525762A,AAC,-0.0275081179809342,0.391904434965798,339,pan-cancer mRNA,CTRPv2,spautin-1,AAC,-0.034991585723598,0.392257015481584,653,pan-cancer mRNA,CTRPv2,pandacostat,AAC,-0.0353213276633979,0.392576368440403,528,pan-cancer mRNA,CTRPv2,BRD-K33199242,AAC,-0.0349944982547187,0.392882628793473,130,pan-cancer mRNA,CTRPv2,bafilomycin A1,AAC,-0.105202812434606,0.396777649159977,61,pan-cancer mRNA,CTRPv2,BRD-K48477130,AAC,-0.0507622220266338,0.39716397405399,143,pan-cancer mRNA,FIMM,lenalidomide,AAC,0.139767221122165,0.400760153070375,419,pan-cancer mRNA,CTRPv2,SB-431542,AAC,0.0345694471469709,0.400815155691752,611,pan-cancer mRNA,CTRPv2,BIRB 0796,AAC,0.035815788022515,0.402024416116024,79,pan-cancer mRNA,CTRPv2,JQ-1:carboplatin (1:1 mol/mol),AAC,-0.0297488906865644,0.402189110696544,383,pan-cancer mRNA,CTRPv2,BRD-K09587429,AAC,-0.0376538925760068,0.402565847692298,109,pan-cancer mRNA,gCSI,bid1870,AAC,0.0509139262089793,0.402873065470006,78,pan-cancer mRNA,GDSC1000,XMD15-27,AAC,0.030959909748877,0.402922643579676,745,pan-cancer mRNA,CTRPv2,niclosamide,AAC,0.0329579872704688,0.40539373535745,490,pan-cancer mRNA,GDSC1000,QL-X-138,AAC,0.0275949156549591,0.406316577839488,582,pan-cancer mRNA,CTRPv2,Bleomycin,AAC,-0.0342597446256489,0.407163231716376,84,pan-cancer mRNA,CTRPv2,navitoclax:gemcitabine (1:1 mol/mol),AAC,-0.0297938934568254,0.410740030780442,476,pan-cancer mRNA,CTRPv2,cediranib,AAC,-0.0469829319615983,0.411013430346134,210,pan-cancer mRNA,FIMM,lapatinib,AAC,-0.135743995095625,0.411512746754316,415,pan-cancer mRNA,CTRPv2,AZD-2281,AAC,-0.0315134093977707,0.411966347857525,51,pan-cancer mRNA,CTRPv2,YM-155,AAC,0.0335357558034478,0.412765145428766,752,pan-cancer mRNA,GDSC1000,Vinorelbine,AAC,0.0309092379707226,0.413236714748032,722,pan-cancer mRNA,CTRPv2,isonicotinohydroxamic acid,AAC,0.0408816632369889,0.417454602762614,370,pan-cancer mRNA,CTRPv2,BRD-K92856060,AAC,0.0322810652111339,0.420178382833544,169,pan-cancer mRNA,CTRPv2,Parthenolide,AAC,-0.0339928566112405,0.42313180024737,531,pan-cancer mRNA,CTRPv2,CHEMBL374350,AAC,-0.0339780126825071,0.423676550565412,222,pan-cancer mRNA,CCLE,Nutlin-3,AAC,0.040975530954827,0.424727110383543,507,pan-cancer mRNA,CTRPv2,selumetinib:BRD-A02303741 (4:1 mol/mol),AAC,0.0301874122162921,0.426860065346608,618,pan-cancer mRNA,CCLE,PHA-665752,AAC,0.0403565183964058,0.428442422315183,554,pan-cancer mRNA,GDSC1000,TAK-715,AAC,-0.0276048580270244,0.43197326716404,670,pan-cancer mRNA,CTRPv2,C6-ceramide,AAC,-0.0310808736057194,0.434138587866224,192,pan-cancer mRNA,CTRPv2,Carboplatin,AAC,-0.0312619446392544,0.434252436828897,197,pan-cancer mRNA,FIMM,Nilotinib,AAC,-0.134121143471798,0.436824112177574,491,pan-cancer mRNA,CTRPv2,methylstat,AAC,-0.0364287605953299,0.437027422140728,439,pan-cancer mRNA,gCSI,GDC-0941,AAC,0.0509208069079559,0.43829524133389,313,pan-cancer mRNA,CTRPv2,ML320,AAC,-0.0303145182372695,0.438950864986393,460,pan-cancer mRNA,CTRPv2,SJ-172550,AAC,-0.0327755546294007,0.439279040232731,642,pan-cancer mRNA,GDSC1000,CMK,AAC,-0.0423223052188588,0.440763686098738,239,pan-cancer mRNA,GDSC1000,GSK1070916,AAC,0.0262361332150564,0.442232427074124,328,pan-cancer mRNA,CTRPv2,nintedanib,AAC,-0.0318441024408753,0.442236304793461,492,pan-cancer mRNA,CTRPv2,Repligen 136,AAC,-0.0308265616784607,0.442948150989162,594,pan-cancer mRNA,CTRPv2,dinaciclib,AAC,0.0383609666874371,0.444679735302319,268,pan-cancer mRNA,CTRPv2,NVP-231,AAC,0.0275221993148747,0.445234887327627,509,pan-cancer mRNA,CTRPv2,ABT-888,AAC,-0.0308644750073842,0.44534429670671,18,pan-cancer mRNA,GDSC1000,A-770041,AAC,0.0405310214379922,0.446006194797681,11,pan-cancer mRNA,CTRPv2,CIL70,AAC,0.0416680895970902,0.447141263348795,235,pan-cancer mRNA,FIMM,RDEA119,AAC,-0.127907376691992,0.450414216531135,592,pan-cancer mRNA,CTRPv2,PF-3758309,AAC,-0.0340983368267323,0.450579500696651,544,pan-cancer mRNA,GDSC1000,Lisitinib,AAC,-0.0276938558311592,0.451267541766994,425,pan-cancer mRNA,CTRPv2,RO4929097,AAC,0.0419290476077386,0.451997152558905,599,pan-cancer mRNA,CTRPv2,BRD-K58730230,AAC,-0.0574080066441768,0.452672170906418,151,pan-cancer mRNA,GDSC1000,CX-5461,AAC,-0.025775794979886,0.453024301779125,253,pan-cancer mRNA,CTRPv2,MG-132,AAC,0.0486282275969336,0.453329922874904,440,pan-cancer mRNA,CTRPv2,cyanoquinoline 11,AAC,0.0441533527313964,0.453404116577651,254,pan-cancer mRNA,CTRPv2,SR1001,AAC,0.031498914753987,0.455771509222999,655,pan-cancer mRNA,CTRPv2,BMS-345541,AAC,-0.0302094243468365,0.456349830080509,87,pan-cancer mRNA,CTRPv2,selumetinib:decitabine (4:1 mol/mol),AAC,0.0271411192740042,0.457535831055623,619,pan-cancer mRNA,FIMM,Roscovitine,AAC,0.124598572170472,0.458063079798274,600,pan-cancer mRNA,CTRPv2,BRD-A02303741:navitoclax (2:1 mol/mol),AAC,-0.0286635117246753,0.4609017786892,96,pan-cancer mRNA,GDSC1000,NSC-87877,AAC,-0.0280707775937432,0.462911376682359,497,pan-cancer mRNA,GDSC1000,Camptothecin,AAC,0.0263424310263248,0.465414824205331,195,pan-cancer mRNA,UHNBreast,Erlotinib,AAC,0.211551818379585,0.467816782737078,287,pan-cancer mRNA,GDSC1000,VX-680,AAC,0.0392772121922468,0.469741834454525,730,pan-cancer mRNA,GDSC1000,CEP-701,AAC,0.0253681152357128,0.46980350883442,211,pan-cancer mRNA,CCLE,Vandetanib,AAC,-0.0366734947756743,0.469940665007279,717,pan-cancer mRNA,GDSC1000,TPCA-1,AAC,-0.0224058074006462,0.471680673079098,699,pan-cancer mRNA,CTRPv2,BRD-K86535717,AAC,0.0551618230179371,0.47189358593647,166,pan-cancer mRNA,CTRPv2,BRD-K34099515,AAC,-0.0577352474905237,0.472388065439952,132,pan-cancer mRNA,GDSC1000,CP466722,AAC,-0.0230618561848032,0.47282153173416,245,pan-cancer mRNA,CCLE,TKI258,AAC,0.0360087858382722,0.475076809027702,694,pan-cancer mRNA,CTRPv2,vorapaxar,AAC,-0.0298883799638256,0.476329672581442,724,pan-cancer mRNA,GDSC1000,CCT007093,AAC,-0.0260808362628351,0.4765054501408,205,pan-cancer mRNA,CTRPv2,oligomycin a,AAC,-0.0274154235900532,0.476699923928239,515,pan-cancer mRNA,CTRPv2,piperlongumine,AAC,-0.0246528973385685,0.477905216796499,562,pan-cancer mRNA,GDSC1000,Gemcitabine,AAC,0.0266453119632919,0.479049279259948,316,pan-cancer mRNA,CTRPv2,BRD-K84807411,AAC,-0.0535037329298779,0.479318750433461,164,pan-cancer mRNA,CTRPv2,BRD-M00053801,AAC,0.0363160837741909,0.480764198768511,176,pan-cancer mRNA,CTRPv2,ML258,AAC,-0.0292999217122938,0.481410053191312,457,pan-cancer mRNA,FIMM,Epothilone B,AAC,0.118358846310975,0.481558285016749,283,pan-cancer mRNA,CTRPv2,NSC95397,AAC,-0.0259270536339256,0.48225240513717,504,pan-cancer mRNA,CTRPv2,IPR-456,AAC,0.0293113221066255,0.484306146508242,366,pan-cancer mRNA,GDSC1000,GW843682X,AAC,0.0371477865634974,0.484925535417126,345,pan-cancer mRNA,CTRPv2,brivanib,AAC,0.0278361243617607,0.487295593219689,187,pan-cancer mRNA,GDSC1000,YM201636,AAC,0.0234746410027906,0.488170700095429,753,pan-cancer mRNA,GDSC1000,KIN001-102,AAC,-0.0221314152034211,0.492710315292766,398,pan-cancer mRNA,CCLE,PD-0332991,AAC,0.035913136415058,0.492742896720444,536,pan-cancer mRNA,GDSC1000,UNC1215,AAC,-0.0253681094597693,0.493201610535368,713,pan-cancer mRNA,CTRPv2,Cytarabine,AAC,-0.0211142084291864,0.493252327592465,257,pan-cancer mRNA,CTRPv2,ML006,AAC,-0.0282957250433599,0.494004848676928,449,pan-cancer mRNA,CTRPv2,BYL-719,AAC,-0.0318331834694981,0.494201250801923,191,pan-cancer mRNA,CTRPv2,Bax channel blocker,AAC,0.0285131099266373,0.500239505289942,65,pan-cancer mRNA,CTRPv2,sitagliptin,AAC,-0.0517934436781828,0.503688164326474,641,pan-cancer mRNA,CTRPv2,Obatoclax Mesylate,AAC,0.0242738521058513,0.506565049112713,514,pan-cancer mRNA,CTRPv2,austocystin d,AAC,-0.0263803854300366,0.509933186636776,43,pan-cancer mRNA,GDSC1000,OSI-027,AAC,0.022087204820811,0.511477382460005,518,pan-cancer mRNA,CTRPv2,SRT-1720,AAC,-0.0268116527300887,0.514514984888073,657,pan-cancer mRNA,CTRPv2,BRD6340,AAC,-0.0249468699541289,0.516743543874506,180,pan-cancer mRNA,CTRPv2,MK-0752,AAC,0.0275374100273024,0.518240689243552,447,pan-cancer mRNA,CTRPv2,TGX221,AAC,-0.0263732460728408,0.520055043896595,684,pan-cancer mRNA,CTRPv2,dexamethasone,AAC,0.023907929130482,0.520677279956097,267,pan-cancer mRNA,CTRPv2,AA-COCF3,AAC,-0.0247150298817053,0.522419038856001,13,pan-cancer mRNA,CTRPv2,vorinostat:carboplatin (1:1 mol/mol),AAC,0.0237334280019541,0.525233167257386,726,pan-cancer mRNA,CTRPv2,CD-437,AAC,-0.0225863329554849,0.526393531633358,209,pan-cancer mRNA,GDSC1000,YK 4-279,AAC,0.0251784859512009,0.526902535869521,750,pan-cancer mRNA,GDSC1000,tivozanib,AAC,-0.0233098978927687,0.529887540604014,693,pan-cancer mRNA,GDSC1000,PF-4708671,AAC,-0.0231496811097824,0.532397677909524,547,pan-cancer mRNA,GDSC1000,MP470,AAC,0.0229844755774668,0.53336950026379,466,pan-cancer mRNA,GDSC1000,Bleomycin,AAC,-0.0239258165662035,0.533545431355123,84,pan-cancer mRNA,CTRPv2,ML311,AAC,-0.0216963645149668,0.534347897170545,458,pan-cancer mRNA,CTRPv2,FGIN-1-27,AAC,-0.0507074245343972,0.53466435096919,295,pan-cancer mRNA,FIMM,RAF265,AAC,0.107617450780355,0.538950207572341,590,pan-cancer mRNA,CTRPv2,NSC23766,AAC,-0.0238955539514933,0.539366171443593,499,pan-cancer mRNA,GDSC1000,PIK-93,AAC,0.0190275843575659,0.540826115864287,561,pan-cancer mRNA,CTRPv2,StemRegenin 1,AAC,0.0234916257854531,0.543243235823117,659,pan-cancer mRNA,CTRPv2,skepinone-L,AAC,0.0332357006118118,0.54332375070557,643,pan-cancer mRNA,GDSC1000,QL-XI-92,AAC,0.0200557219947527,0.545170549477702,583,pan-cancer mRNA,CTRPv2,PDMP,AAC,-0.0254022056509278,0.546093312506025,540,pan-cancer mRNA,FIMM,Sorafenib,AAC,-0.101984202845393,0.548572699561261,651,pan-cancer mRNA,GDSC1000,Bryostatin 1,AAC,-0.0225541666117002,0.550422028727936,188,pan-cancer mRNA,GDSC1000,BIX02189,AAC,-0.0201693444752978,0.551574905117214,82,pan-cancer mRNA,GDSC1000,JW-7-52-1,AAC,0.031765657372016,0.552677252392097,392,pan-cancer mRNA,CTRPv2,L-685458,AAC,-0.0234464147121739,0.55657690173665,413,pan-cancer mRNA,CTRPv2,Cerulenin,AAC,0.020867675073451,0.557101427735678,213,pan-cancer mRNA,CTRPv2,IC-87114,AAC,-0.0235634914405738,0.557541319303542,357,pan-cancer mRNA,CTRPv2,barasertib,AAC,-0.020816605295025,0.558194130430404,63,pan-cancer mRNA,CTRPv2,necrosulfonamide,AAC,0.0251858616523743,0.558826986676505,484,pan-cancer mRNA,GDSC1000,phenformin,AAC,-0.0195384750339184,0.560522091065569,556,pan-cancer mRNA,GDSC1000,GSK429286A,AAC,0.020514854277506,0.560597652104267,337,pan-cancer mRNA,CTRPv2,AZD4547,AAC,-0.0241948584219485,0.561220445299243,55,pan-cancer mRNA,CTRPv2,Ko-143,AAC,-0.0236787453413591,0.561920973277964,405,pan-cancer mRNA,GDSC1000,EHT 1864,AAC,-0.021133176848289,0.562691219364418,275,pan-cancer mRNA,GDSC1000,masitinib,AAC,-0.0201619859250517,0.563544427443924,434,pan-cancer mRNA,CTRPv2,decitabine:carboplatin (1:1 mol/mol),AAC,-0.0180712060340136,0.563591664134729,265,pan-cancer mRNA,CCLE,AZD0530,AAC,-0.0295152291006335,0.564832409786558,53,pan-cancer mRNA,CTRPv2,BRD-K55116708,AAC,0.0227465449976748,0.566716091075166,149,pan-cancer mRNA,GDSC1000,NG-25,AAC,-0.018343214413476,0.567231248151339,489,pan-cancer mRNA,GDSC1000,Genentech Cpd 10,AAC,-0.0192753393305054,0.567851882486724,317,pan-cancer mRNA,CTRPv2,UNC0638,AAC,-0.0229384697008583,0.56791751477173,711,pan-cancer mRNA,CTRPv2,selumetinib:navitoclax (8:1 mol/mol),AAC,-0.0231055768144445,0.569061914197896,623,pan-cancer mRNA,CTRPv2,tivantinib,AAC,0.0272433116253849,0.56910672601173,692,pan-cancer mRNA,CTRPv2,BRD-A71883111,AAC,-0.0228940724773648,0.574006932507812,98,pan-cancer mRNA,CTRPv2,pifithrin-alpha,AAC,0.0233519526608118,0.574044784263314,559,pan-cancer mRNA,GDSC1000,lenalidomide,AAC,0.0215024387755711,0.574533610254917,419,pan-cancer mRNA,GDSC1000,Tipifarnib,AAC,-0.0214149851737908,0.575056308565973,691,pan-cancer mRNA,FIMM,Vandetanib,AAC,-0.0985801802599425,0.575547089704414,717,pan-cancer mRNA,CTRPv2,BRD-K13999467,AAC,-0.0226110708864484,0.576415380026098,112,pan-cancer mRNA,CTRPv2,erastin,AAC,-0.021615402495305,0.576666617039992,284,pan-cancer mRNA,UHNBreast,lapatinib,AAC,0.170422682731069,0.577764687134157,415,pan-cancer mRNA,CTRPv2,marinopyrrole A,AAC,0.0266936130075086,0.577850613743825,433,pan-cancer mRNA,FIMM,AMG-706,AAC,-0.0919735742272459,0.577973823792448,31,pan-cancer mRNA,FIMM,17-AAG,AAC,0.0990730613551564,0.578145383067853,3,pan-cancer mRNA,GDSC1000,Vinblastine,AAC,0.0201290992744576,0.579341141570914,720,pan-cancer mRNA,GDSC1000,QL-VIII-58,AAC,-0.0266101498711059,0.581619402920359,581,pan-cancer mRNA,GDSC1000,Rapamycin,AAC,-0.028521944937848,0.582590093543682,591,pan-cancer mRNA,CTRPv2,BRD-K49290616,AAC,-0.0460839076279169,0.582687955274661,144,pan-cancer mRNA,GDSC1000,FMK,AAC,0.0219486394366247,0.58359986080959,300,pan-cancer mRNA,CTRPv2,UNC0638:navitoclax (1:1 mol/mol),AAC,-0.0218829171726112,0.584935183055189,712,pan-cancer mRNA,CTRPv2,BRD-K66453893,AAC,-0.0188423153507404,0.585609015540415,155,pan-cancer mRNA,CTRPv2,MI-1,AAC,0.0237625385864878,0.586506612826986,442,pan-cancer mRNA,CTRPv2,FK866,AAC,0.022873437957301,0.586530116613707,298,pan-cancer mRNA,CTRPv2,ifosfamide,AAC,-0.033050925370369,0.586921954753477,359,pan-cancer mRNA,GDSC1000,shikonin,AAC,-0.0199116321977132,0.588247560560637,634,pan-cancer mRNA,CTRPv2,UNC0321,AAC,-0.0220142744686476,0.588902152708575,710,pan-cancer mRNA,GDSC1000,ZM-447439,AAC,-0.0206714618983038,0.590121503031891,758,pan-cancer mRNA,CTRPv2,Gefitinib,AAC,0.0209496117606792,0.595968927860437,314,pan-cancer mRNA,GDSC1000,IOX2,AAC,0.0191765834151936,0.598456636696416,364,pan-cancer mRNA,CTRPv2,BRD-K09344309,AAC,-0.0475307458643192,0.599572331513856,108,pan-cancer mRNA,CTRPv2,PD318088,AAC,0.0197466662840726,0.599742632946691,538,pan-cancer mRNA,CTRPv2,BRD-K41597374,AAC,-0.020380948229432,0.600523443887713,138,pan-cancer mRNA,CTRPv2,ABT-737,AAC,-0.0206031729317973,0.601694941858674,17,pan-cancer mRNA,CTRPv2,azacitidine,AAC,0.0219398949905687,0.602020173281275,50,pan-cancer mRNA,CTRPv2,GW-405833,AAC,-0.0198415905495063,0.602417263390261,344,pan-cancer mRNA,GDSC1000,S-Trityl-L-cysteine,AAC,-0.0274156425380771,0.604682553555303,603,pan-cancer mRNA,CTRPv2,ceranib-2,AAC,0.0187467854063178,0.605818863415264,212,pan-cancer mRNA,CTRPv2,NSC 74859,AAC,-0.0218440591849289,0.608194736979248,495,pan-cancer mRNA,CTRPv2,ciclopirox,AAC,-0.0179466752353594,0.611089516853851,228,pan-cancer mRNA,GDSC1000,FK866,AAC,0.0167218434600643,0.61177920351513,298,pan-cancer mRNA,CTRPv2,BRD-K13185470,AAC,-0.0372233971758968,0.614439674142018,111,pan-cancer mRNA,CTRPv2,erlotinib:PLX-4032 (2:1 mol/mol),AAC,0.0203826557213414,0.615340676481512,288,pan-cancer mRNA,GDSC1000,T0901317,AAC,0.0179947744139771,0.615343705593615,666,pan-cancer mRNA,GDSC1000,Crizotinib,AAC,0.0274749769690591,0.615506037098554,248,pan-cancer mRNA,CTRPv2,SNS-032,AAC,-0.0194553489784728,0.616071831953349,648,pan-cancer mRNA,CTRPv2,HBX-41108,AAC,0.0225648277468706,0.617089840305503,346,pan-cancer mRNA,GDSC1000,LAQ824,AAC,0.0182497702905189,0.618173387859986,416,pan-cancer mRNA,CTRPv2,bendamustine,AAC,0.0205629221451478,0.620539458947419,70,pan-cancer mRNA,GDSC1000,KIN001-236,AAC,-0.017796556681991,0.623387748331492,400,pan-cancer mRNA,GDSC1000,WH-4-023,AAC,-0.0248923004335174,0.627761718914024,733,pan-cancer mRNA,GDSC1000,STF-62247,AAC,-0.0171624210679953,0.628495251989624,661,pan-cancer mRNA,CTRPv2,ML050,AAC,0.0196012317509716,0.628549841033862,451,pan-cancer mRNA,FIMM,BIBW2992,AAC,0.0758941313487564,0.628943847611778,76,pan-cancer mRNA,gCSI,Irinotecan,AAC,0.0280786082211801,0.630285926896874,367,pan-cancer mRNA,CTRPv2,16-beta-bromoandrosterone,AAC,-0.0199925424943581,0.630623644175045,2,pan-cancer mRNA,CTRPv2,narciclasine,AAC,-0.0166068785206491,0.630987095439232,474,pan-cancer mRNA,GDSC1000,Axitinib,AAC,-0.0182749238449477,0.632741984144804,47,pan-cancer mRNA,CTRPv2,STF-31,AAC,0.0182497670699961,0.634922032348381,660,pan-cancer mRNA,CTRPv2,AZD6244,AAC,0.0178941118122855,0.636715364819244,56,pan-cancer mRNA,CTRPv2,Bosutinib,AAC,-0.0176126113796492,0.639109267450408,93,pan-cancer mRNA,CTRPv2,PHA-793887,AAC,-0.0162007656018756,0.63929663496239,555,pan-cancer mRNA,GDSC1000,Dasatinib,AAC,-0.0236844612730582,0.642674794758134,262,pan-cancer mRNA,CTRPv2,CHM-1,AAC,-0.0165284260905465,0.642700099673955,225,pan-cancer mRNA,CCLE,Sorafenib,AAC,-0.023259112191325,0.646349424802502,651,pan-cancer mRNA,GDSC1000,tubastatin A,AAC,-0.0151617292733122,0.648821852347947,707,pan-cancer mRNA,CTRPv2,BRD-K16147474,AAC,0.0201295310178251,0.649835419462752,115,pan-cancer mRNA,CTRPv2,alvocidib,AAC,0.0230445058336558,0.650443867464336,29,pan-cancer mRNA,CTRPv2,tretinoin:navitoclax (4:1 mol/mol),AAC,-0.0169214292106476,0.653428171923612,701,pan-cancer mRNA,CTRPv2,Erlotinib,AAC,-0.0168717717052945,0.65590440465496,287,pan-cancer mRNA,GDSC1000,ZSTK474,AAC,-0.0148127046310888,0.657883657342344,759,pan-cancer mRNA,GDSC1000,YM-155,AAC,0.0158537190944615,0.660283861040568,752,pan-cancer mRNA,CTRPv2,RITA,AAC,-0.0171381913804643,0.662049383209853,597,pan-cancer mRNA,CTRPv2,manumycin A,AAC,-0.0154361215048231,0.662677987448909,432,pan-cancer mRNA,GDSC1000,XMD14-99,AAC,-0.0155599412719676,0.662992297324411,744,pan-cancer mRNA,CTRPv2,BRD-K79669418,AAC,-0.0263709826578178,0.663062702294641,162,pan-cancer mRNA,CTRPv2,MLN4924,AAC,0.0162982433426481,0.66465167777843,464,pan-cancer mRNA,CTRPv2,Bexarotene,AAC,-0.0172018551780403,0.665790992986571,72,pan-cancer mRNA,CCLE,LBW242,AAC,0.0223234713246722,0.66599027303,417,pan-cancer mRNA,CTRPv2,JQ-1:MK-0752 (1:1 mol/mol),AAC,-0.0158386042516589,0.667019753191422,384,pan-cancer mRNA,GDSC1000,Cisplatin,AAC,0.0156132006559344,0.669122123804115,237,pan-cancer mRNA,CTRPv2,ruxolitinib,AAC,-0.01610446712164,0.671806899903906,602,pan-cancer mRNA,CTRPv2,necrostatin-7,AAC,0.0172309145512148,0.676416732929413,483,pan-cancer mRNA,CTRPv2,BRD-K27188169,AAC,-0.0250043153326026,0.68046538370727,121,pan-cancer mRNA,FIMM,serdemetan,AAC,0.064893313946194,0.681296720906911,630,pan-cancer mRNA,FIMM,Bortezomib,AAC,-0.0611726401616465,0.681740483775623,92,pan-cancer mRNA,CTRPv2,valdecoxib,AAC,0.0158395713103797,0.682270904528812,715,pan-cancer mRNA,CTRPv2,BRD-K02251932,AAC,-0.0177108058214564,0.682300917676995,102,pan-cancer mRNA,GDSC1000,HG-5-88-01,AAC,-0.0196222702923964,0.685715308928517,349,pan-cancer mRNA,FIMM,GDC-0449,AAC,0.0709704133401356,0.685988225473911,311,pan-cancer mRNA,GDSC1000,SN-38,AAC,0.0144707896304864,0.686656717770212,647,pan-cancer mRNA,GDSC1000,AZD7762,AAC,0.0139031472696712,0.687996363894614,58,pan-cancer mRNA,CTRPv2,simvastatin,AAC,0.0171072731472692,0.688401498096165,639,pan-cancer mRNA,GDSC1000,Nilotinib,AAC,-0.0155188316641535,0.690508527143414,491,pan-cancer mRNA,CTRPv2,lenvatinib,AAC,-0.0159658279703405,0.691627355674276,420,pan-cancer mRNA,CTRPv2,SMER-3,AAC,0.0168243528459421,0.691754809758869,646,pan-cancer mRNA,CTRPv2,KHS101,AAC,-0.0157874559368378,0.694124367003881,395,pan-cancer mRNA,CTRPv2,BRD-K30019337,AAC,-0.0285868271682919,0.695550779436513,128,pan-cancer mRNA,GDSC1000,AZ628,AAC,0.0195300216965028,0.696608653765849,49,pan-cancer mRNA,CTRPv2,PRIMA-1-Met,AAC,0.0239364547660821,0.696831019112552,571,pan-cancer mRNA,UHNBreast,paclitaxel,AAC,0.125747357539662,0.696975790565257,526,pan-cancer mRNA,GDSC1000,GSK2126458,AAC,0.0132896547763639,0.698708732191475,332,pan-cancer mRNA,FIMM,Imatinib,AAC,0.0684803840296605,0.700636831174773,361,pan-cancer mRNA,CTRPv2,A-804598,AAC,-0.0190476878986022,0.700897240017931,12,pan-cancer mRNA,FIMM,Panobinostat,AAC,0.0445867081353673,0.701121075962537,529,pan-cancer mRNA,CTRPv2,PD 153035,AAC,-0.0172199765608626,0.702362802755958,534,pan-cancer mRNA,FIMM,AP-24534,AAC,-0.0649030052652954,0.703437497646939,32,pan-cancer mRNA,CTRPv2,erismodegib,AAC,0.015993712167854,0.703615074906049,285,pan-cancer mRNA,GDSC1000,VX-11e,AAC,-0.0135611533875619,0.70488380756431,729,pan-cancer mRNA,CTRPv2,navitoclax:sorafenib (1:1 mol/mol),AAC,-0.0143174532436319,0.705669045658653,481,pan-cancer mRNA,CTRPv2,BRD8899,AAC,0.0157331391527703,0.706958496538598,181,pan-cancer mRNA,CTRPv2,GMX-1778,AAC,-0.0144627408311703,0.70708030345882,319,pan-cancer mRNA,CTRPv2,I-BET151,AAC,-0.0127893944278611,0.707570182172884,354,pan-cancer mRNA,GDSC1000,JNJ-26854165,AAC,-0.013224761740101,0.715308432445678,379,pan-cancer mRNA,CTRPv2,navitoclax:birinapant (1:1 mol/mol),AAC,-0.0142112247650923,0.716507775517815,475,pan-cancer mRNA,FIMM,PD-0332991,AAC,-0.059248318035174,0.720628304510378,536,pan-cancer mRNA,CTRPv2,selumetinib:GDC-0941 (4:1 mol/mol),AAC,-0.0138175075898375,0.721146455510089,620,pan-cancer mRNA,CTRPv2,selumetinib:UNC0638 (4:1 mol/mol),AAC,0.0134520677962745,0.725226666061182,627,pan-cancer mRNA,GDSC1000,NVP-BEZ235,AAC,-0.0127486052461455,0.725402511390028,511,pan-cancer mRNA,CTRPv2,ciclosporin,AAC,-0.0141806628283027,0.72775074959414,229,pan-cancer mRNA,GDSC1000,JW-7-24-1,AAC,-0.0110960379004075,0.728921814566375,391,pan-cancer mRNA,GDSC1000,FR-180204,AAC,0.0127427788972121,0.729459548140468,304,pan-cancer mRNA,CTRPv2,PF-543,AAC,0.0140604019013012,0.73010160695391,549,pan-cancer mRNA,CTRPv2,triptolide,AAC,-0.0130834470420981,0.732251764967719,706,pan-cancer mRNA,CTRPv2,neopeltolide,AAC,-0.0248861592226076,0.733676934136958,487,pan-cancer mRNA,CTRPv2,CR-1-31B,AAC,0.0120353447110022,0.735077966075371,247,pan-cancer mRNA,GDSC1000,GSK-1904529A,AAC,-0.0121243404739199,0.737928953707929,322,pan-cancer mRNA,GDSC1000,SB 505124,AAC,-0.01230460034084,0.739768865142692,608,pan-cancer mRNA,CTRPv2,BIBR-1532,AAC,-0.0135258031926062,0.740490140852885,75,pan-cancer mRNA,GDSC1000,BMS-345541,AAC,-0.0110672370117143,0.742619548078122,87,pan-cancer mRNA,CTRPv2,prima-1,AAC,-0.0111417151221068,0.743583434832868,570,pan-cancer mRNA,CTRPv2,YL54,AAC,0.0140417778595662,0.744270229457725,751,pan-cancer mRNA,CTRPv2,isoliquiritigenin,AAC,0.0238344537578304,0.745153286090381,369,pan-cancer mRNA,FIMM,CEP-701,AAC,0.0397678133144583,0.748956134224826,211,pan-cancer mRNA,CTRPv2,BRD-K48334597,AAC,-0.0226006632671018,0.750721806661193,142,pan-cancer mRNA,GDSC1000,QS11,AAC,-0.01182904620887,0.756425012693155,586,pan-cancer mRNA,GDSC1000,Cetuximab,AAC,0.0107908439030811,0.758880304586679,214,pan-cancer mRNA,FIMM,ATRA,AAC,-0.0462028767952217,0.762383220907716,42,pan-cancer mRNA,GDSC1000,CH5424802,AAC,0.0109802635991988,0.763440675291896,220,pan-cancer mRNA,GDSC1000,OSU-03012,AAC,-0.0111246173629238,0.763739332821574,521,pan-cancer mRNA,CTRPv2,Compound 23 citrate,AAC,-0.0113873201190577,0.76438733562975,243,pan-cancer mRNA,GDSC1000,Imatinib,AAC,0.0163974057415645,0.767474114923181,361,pan-cancer mRNA,CTRPv2,BRD-K52037352,AAC,-0.0133474180287047,0.768525045722629,148,pan-cancer mRNA,CTRPv2,semagacestat,AAC,-0.0117219489866644,0.769600939600944,629,pan-cancer mRNA,CTRPv2,AZD-7545,AAC,0.0116794275070385,0.770117796567028,52,pan-cancer mRNA,CTRPv2,BRD-K07442505,AAC,-0.0116662712600407,0.771042001179476,107,pan-cancer mRNA,CTRPv2,temsirolimus,AAC,-0.0157918903888226,0.773007981605033,680,pan-cancer mRNA,GDSC1000,KIN001-270,AAC,-0.0105319275010589,0.773400396944834,404,pan-cancer mRNA,CTRPv2,trifluoperazine,AAC,0.0124487572557145,0.773716591800589,705,pan-cancer mRNA,CTRPv2,BRD-K55473186,AAC,-0.0148029368672615,0.773962767310751,150,pan-cancer mRNA,GDSC1000,CGP-082996,AAC,0.0153723955148062,0.774678972797797,217,pan-cancer mRNA,FIMM,BI-2536,AAC,0.0368437389756646,0.775336717195876,74,pan-cancer mRNA,GDSC1000,KIN001-266,AAC,-0.010470511759379,0.77700981043844,403,pan-cancer mRNA,CTRPv2,ouabain,AAC,-0.0108609476067056,0.777615563340087,522,pan-cancer mRNA,CTRPv2,ELCPK,AAC,-0.0160839449004092,0.778773267279117,277,pan-cancer mRNA,CTRPv2,tigecycline,AAC,0.0149916286688543,0.779058236975449,689,pan-cancer mRNA,CTRPv2,CAY10594,AAC,0.0118874558262211,0.77933699731717,201,pan-cancer mRNA,gCSI,Erlotinib,AAC,-0.0170967650285623,0.781933470725061,287,pan-cancer mRNA,CTRPv2,GW843682X,AAC,-0.0105879620252823,0.784240772663747,345,pan-cancer mRNA,CTRPv2,BRD1835,AAC,0.0114795527859565,0.785285166700347,178,pan-cancer mRNA,CTRPv2,BEC,AAC,-0.020756865191842,0.789713467831171,68,pan-cancer mRNA,CTRPv2,rigosertib,AAC,-0.00968048617779138,0.7897230224936,596,pan-cancer mRNA,FIMM,Crizotinib,AAC,0.0474692348924535,0.790374504687673,248,pan-cancer mRNA,CTRPv2,QS11,AAC,0.0199405988047147,0.79244895686443,586,pan-cancer mRNA,FIMM,AZD0530,AAC,0.042625110562712,0.795192393403064,53,pan-cancer mRNA,CTRPv2,AC55649,AAC,-0.0108056904888953,0.798135630784857,20,pan-cancer mRNA,GDSC1000,Cyclopamine,AAC,0.0139497962611159,0.799416452774994,255,pan-cancer mRNA,FIMM,BMS-754807,AAC,-0.0333678519873322,0.801559082772751,91,pan-cancer mRNA,CTRPv2,PRL-3 Inhibitor I,AAC,0.0107313733601633,0.801960662352774,572,pan-cancer mRNA,GDSC1000,XMD8-85,AAC,-0.0133049819626354,0.802126873893974,746,pan-cancer mRNA,CTRPv2,carboplatin:UNC0638 (2:1 mol/mol),AAC,-0.0101499639249483,0.803994577626573,199,pan-cancer mRNA,CTRPv2,CAY10576,AAC,0.010547063754058,0.807340770754583,200,pan-cancer mRNA,CTRPv2,tubastatin A,AAC,-0.0137623788640114,0.807534482238332,707,pan-cancer mRNA,GDSC1000,Doxorubicin,AAC,0.00930441736173128,0.807604447808085,273,pan-cancer mRNA,CTRPv2,VU0155056,AAC,0.0097936959402909,0.809780751630231,728,pan-cancer mRNA,GDSC1000,TL-1-85,AAC,-0.00771590057876858,0.81209535062284,695,pan-cancer mRNA,CTRPv2,fluvastatin,AAC,-0.00935802212689686,0.818247262305899,299,pan-cancer mRNA,CTRPv2,ABT-263,AAC,-0.00873405666048151,0.819553232096547,16,pan-cancer mRNA,CTRPv2,XL765,AAC,0.00954908259428208,0.820467325472679,741,pan-cancer mRNA,GDSC1000,VX-702,AAC,-0.008523534983705,0.82084212932196,731,pan-cancer mRNA,CTRPv2,R428,AAC,-0.0103980178919105,0.822604312003316,589,pan-cancer mRNA,CTRPv2,Curcumin,AAC,-0.00844596617784129,0.822709415538821,252,pan-cancer mRNA,GDSC1000,AZD8055,AAC,-0.00785661407391314,0.822996619146752,59,pan-cancer mRNA,CTRPv2,LY-2183240,AAC,0.00779231953410983,0.823751807366282,430,pan-cancer mRNA,GDSC1000,TGX221,AAC,0.0108804245744971,0.823880719997579,684,pan-cancer mRNA,CTRPv2,QW-BI-011,AAC,-0.0160712562473194,0.824375088085152,588,pan-cancer mRNA,CTRPv2,BRD-K99584050,AAC,-0.0135648012109254,0.824544371790728,175,pan-cancer mRNA,FIMM,BIRB 0796,AAC,0.0403964818266621,0.826562947640347,79,pan-cancer mRNA,CTRPv2,HC-067047,AAC,0.00921123084066526,0.827094657641033,347,pan-cancer mRNA,CTRPv2,Panobinostat,AAC,-0.00794548470208616,0.827447446469119,529,pan-cancer mRNA,CTRPv2,isoevodiamine,AAC,-0.00770470458400453,0.83000887319383,368,pan-cancer mRNA,CTRPv2,BRD-K29086754,AAC,-0.0167921503995406,0.832737145980758,126,pan-cancer mRNA,CTRPv2,ML203,AAC,0.0088047290291918,0.834441893879737,454,pan-cancer mRNA,GDSC1000,embelin,AAC,0.00788555309055947,0.835886755532299,280,pan-cancer mRNA,GDSC1000,Bexarotene,AAC,0.00782836150336927,0.838892119015142,72,pan-cancer mRNA,CTRPv2,BRD-A02303741:carboplatin (1:1 mol/mol),AAC,0.00842333454082799,0.840048097907921,95,pan-cancer mRNA,GDSC1000,681640,AAC,-0.00800080400463993,0.840325538855037,8,pan-cancer mRNA,FIMM,Sunitinib,AAC,0.0353299226188958,0.840879308603636,663,pan-cancer mRNA,GDSC1000,CUDC-101,AAC,0.00671580963870873,0.841560393885292,251,pan-cancer mRNA,GDSC1000,XAV-939,AAC,0.00732559789153978,0.843330755558092,739,pan-cancer mRNA,CTRPv2,BRD-K70511574,AAC,0.00701573433986252,0.843673852478371,157,pan-cancer mRNA,CTRPv2,KU-55933,AAC,0.00791019158754122,0.844168267220687,409,pan-cancer mRNA,GDSC1000,BHG712,AAC,-0.00630735929669596,0.844434697976813,73,pan-cancer mRNA,CTRPv2,crizotinib:PLX-4032 (2:1 mol/mol),AAC,-0.00739386267522074,0.845190814791229,249,pan-cancer mRNA,CTRPv2,darinaparsin,AAC,0.011437383536676,0.846181693737006,261,pan-cancer mRNA,CTRPv2,epigallocatechin-3-monogallate,AAC,-0.00774075402295288,0.848084732823873,281,pan-cancer mRNA,CTRPv2,lomeguatrib,AAC,-0.00765459165934666,0.848692546615046,426,pan-cancer mRNA,GDSC1000,Mitomycin-C,AAC,-0.00722669114864914,0.849067145920516,445,pan-cancer mRNA,CTRPv2,lapatinib,AAC,-0.00767255573616395,0.84926084450652,415,pan-cancer mRNA,CTRPv2,SR-II-138A,AAC,0.00645489378016459,0.853231157427452,654,pan-cancer mRNA,CTRPv2,WAY-362450,AAC,0.00745056151555384,0.85718924743259,732,pan-cancer mRNA,CCLE,TAE684,AAC,-0.0087088238179506,0.85850850622103,669,pan-cancer mRNA,CTRPv2,gossypol,AAC,0.00724106867993043,0.858727929346578,321,pan-cancer mRNA,CTRPv2,BMS-270394,AAC,0.00703515232081476,0.863857860891486,86,pan-cancer mRNA,CTRPv2,OSI-930,AAC,-0.00676605908195831,0.864640638423333,520,pan-cancer mRNA,GDSC1000,MPS-1-IN-1,AAC,0.00585202927690868,0.865241605690479,467,pan-cancer mRNA,CCLE,Nilotinib,AAC,0.0092138336268907,0.866423300543394,491,pan-cancer mRNA,CTRPv2,LE-135,AAC,0.00675557694094044,0.867145613045302,418,pan-cancer mRNA,CTRPv2,tacedinaline,AAC,-0.00695026597775547,0.867828599211328,667,pan-cancer mRNA,CTRPv2,Mdivi-1,AAC,-0.00667790501430442,0.869584820018806,435,pan-cancer mRNA,GDSC1000,Y-39983,AAC,-0.00568699795436092,0.869873597630844,749,pan-cancer mRNA,CTRPv2,clofarabine,AAC,0.00523708576712246,0.870605705194548,238,pan-cancer mRNA,CTRPv2,apicidin,AAC,0.00535461772750561,0.873510220367981,33,pan-cancer mRNA,CTRPv2,Platin,AAC,0.00622652051450548,0.877262656522034,566,pan-cancer mRNA,CTRPv2,AZ-3146,AAC,-0.00608070255659032,0.877594203974246,48,pan-cancer mRNA,CTRPv2,palmostatin B,AAC,0.00746664209565956,0.878481105815888,527,pan-cancer mRNA,GDSC1000,KIN001-244,AAC,0.0051166247914217,0.879600793573244,401,pan-cancer mRNA,GDSC1000,DMOG,AAC,0.00528755632146423,0.880169600769587,270,pan-cancer mRNA,GDSC1000,BIRB 0796,AAC,0.00558017570480441,0.880489260850297,79,pan-cancer mRNA,CTRPv2,YK 4-279,AAC,0.0051995435949186,0.882387817983921,750,pan-cancer mRNA,GDSC1000,AZD6482,AAC,-0.0050064547917232,0.884482622913641,57,pan-cancer mRNA,GDSC1000,THZ-2-102-1,AAC,0.00469871127140666,0.886056805082975,687,pan-cancer mRNA,GDSC1000,TAE684,AAC,-0.00775329632452673,0.886639584115578,669,pan-cancer mRNA,FIMM,paclitaxel,AAC,0.019389126732319,0.887080503337617,526,pan-cancer mRNA,CTRPv2,procarbazine,AAC,-0.0060339645981935,0.887714372975495,573,pan-cancer mRNA,GDSC1000,HG-5-113-01,AAC,-0.00669909592314486,0.889283275346713,348,pan-cancer mRNA,CTRPv2,KU-60019,AAC,0.00508285478316868,0.892622376857837,410,pan-cancer mRNA,CTRPv2,ISOX:bortezomib (250:1 mol/mol),AAC,0.00491562408391181,0.896416011708308,372,pan-cancer mRNA,CCLE,PD-0325901,AAC,-0.00598571346646868,0.896554435512005,535,pan-cancer mRNA,CTRPv2,CHEMBL1222381,AAC,0.00474702171168489,0.897267796608129,221,pan-cancer mRNA,CTRPv2,selumetinib:tretinoin (2:1 mol/mol),AAC,0.00489478727329154,0.898378271211816,626,pan-cancer mRNA,CTRPv2,AGK-2,AAC,0.00503226564691644,0.905613723444928,24,pan-cancer mRNA,CTRPv2,triazolothiadiazine,AAC,0.00388891038734765,0.906215903214486,702,pan-cancer mRNA,GDSC1000,Docetaxel,AAC,-0.00392496799305762,0.906491300936595,271,pan-cancer mRNA,CTRPv2,SU11274,AAC,-0.00441642413221142,0.907816934760716,662,pan-cancer mRNA,GDSC1000,piperlongumine,AAC,-0.00396809937217033,0.910990580379999,562,pan-cancer mRNA,CTRPv2,AT-406,AAC,-0.00569197264049408,0.91187245116136,38,pan-cancer mRNA,GDSC1000,RDEA119,AAC,-0.00353836297561559,0.913726798969444,592,pan-cancer mRNA,GDSC1000,GDC-0941,AAC,0.00380119435622087,0.914697698524832,313,pan-cancer mRNA,CTRPv2,vorinostat:navitoclax (4:1 mol/mol),AAC,0.00406019410863484,0.914775350490264,727,pan-cancer mRNA,CTRPv2,BRD-K42260513,AAC,-0.00623313208224317,0.916911160679744,139,pan-cancer mRNA,CTRPv2,FQI-1,AAC,-0.00547110478476789,0.917919203595279,302,pan-cancer mRNA,GDSC1000,TL-2-105,AAC,0.00347226401275729,0.920928162208646,696,pan-cancer mRNA,GDSC1000,IPA-3,AAC,0.00346063837822554,0.922381041550365,365,pan-cancer mRNA,CTRPv2,Sunitinib,AAC,-0.00361586457449849,0.923017435199526,663,pan-cancer mRNA,GDSC1000,CI-1040,AAC,-0.00335136067515952,0.923586579469766,226,pan-cancer mRNA,CTRPv2,BRD-K97651142,AAC,-0.00382932250803606,0.924518201867535,173,pan-cancer mRNA,CCLE,Crizotinib,AAC,-0.00462867075228201,0.925756621748443,248,pan-cancer mRNA,FIMM,Bosutinib,AAC,0.0349155893596202,0.926455292350298,93,pan-cancer mRNA,GDSC1000,A-443654,AAC,-0.00492915360515352,0.926689679556214,10,pan-cancer mRNA,GDSC1000,AG-014699,AAC,0.0032704147875768,0.92825241100922,22,pan-cancer mRNA,CCLE,AZD6244,AAC,-0.00423884351566845,0.928666059147136,56,pan-cancer mRNA,CTRPv2,LY-2157299,AAC,0.00698292401126729,0.930211304865261,429,pan-cancer mRNA,CTRPv2,CD-1530,AAC,-0.00369713730905749,0.930946488668253,208,pan-cancer mRNA,GDSC1000,GSK-650394,AAC,0.00314000130935726,0.934663584225205,324,pan-cancer mRNA,GDSC1000,AR-42,AAC,-0.00245974582842917,0.940310918469546,34,pan-cancer mRNA,CTRPv2,thalidomide,AAC,-0.00391321530846203,0.9444582692699,685,pan-cancer mRNA,GDSC1000,Salubrinal,AAC,-0.00375480152988478,0.944708392330699,606,pan-cancer mRNA,CTRPv2,BRD-K50799972,AAC,0.00287287261535466,0.945283738782028,145,pan-cancer mRNA,CTRPv2,VAF-347,AAC,-0.00344326783083877,0.946244062802036,714,pan-cancer mRNA,FIMM,Axitinib,AAC,-0.0107749856978688,0.94631920275615,47,pan-cancer mRNA,CTRPv2,PF-750,AAC,0.0028737746458439,0.946580601384716,552,pan-cancer mRNA,CTRPv2,BRD9647,AAC,0.00272996231325132,0.94730832726523,183,pan-cancer mRNA,GDSC1000,EX-527,AAC,-0.00242687457319703,0.948380612137705,293,pan-cancer mRNA,FIMM,AZD6244,AAC,-0.0112757106011892,0.949192174857409,56,pan-cancer mRNA,GDSC1000,MK-2206,AAC,0.00236953434077627,0.95039479617577,448,pan-cancer mRNA,GDSC1000,QL-XII-61,AAC,-0.00306574441228245,0.950901083996572,585,pan-cancer mRNA,CTRPv2,BRD-K19103580,AAC,-0.00249670377758803,0.952139798995409,117,pan-cancer mRNA,GDSC1000,paclitaxel,AAC,-0.00306840730155372,0.953244455518037,526,pan-cancer mRNA,GDSC1000,BX-912,AAC,-0.00187951722887537,0.953778218973607,190,pan-cancer mRNA,CTRPv2,CIL55A,AAC,0.00292762410449865,0.96025217880115,233,pan-cancer mRNA,CTRPv2,BRD8958,AAC,-0.00205908322255718,0.9615247364111,182,pan-cancer mRNA,GDSC1000,JQ12,AAC,-0.00178975088873311,0.962046031020935,388,pan-cancer mRNA,GDSC1000,Talazoparib,AAC,-0.00168964283847441,0.962656950953407,671,pan-cancer mRNA,CTRPv2,RG-108,AAC,0.00182032340182564,0.962927925764095,595,pan-cancer mRNA,FIMM,Vorinostat,AAC,-0.00723690578680116,0.963436278871674,725,pan-cancer mRNA,GDSC1000,ruxolitinib,AAC,0.00164822451059095,0.963603414341221,602,pan-cancer mRNA,GDSC1000,CAY10603,AAC,-0.00148479671040709,0.963769539242319,202,pan-cancer mRNA,CTRPv2,BRD-K14844214,AAC,-0.00184991448515583,0.965074565768078,113,pan-cancer mRNA,GDSC1000,pac-1,AAC,-0.00159243984476507,0.967225023455413,525,pan-cancer mRNA,CTRPv2,pitstop2,AAC,-0.00196641547515888,0.968476642754108,564,pan-cancer mRNA,CTRPv2,BRD-K96431673,AAC,-0.00284952783502091,0.969911748072271,171,pan-cancer mRNA,CTRPv2,BRD-K04800985,AAC,-0.00141789501891476,0.973101696593586,106,pan-cancer mRNA,CTRPv2,PX-12,AAC,0.000930149753492392,0.976637704252126,577,pan-cancer mRNA,GDSC1000,Z-LLNle-CHO,AAC,0.00134522608136003,0.978418989425584,754,pan-cancer mRNA,GDSC1000,PD-0325901,AAC,-0.000884325374771106,0.979394613385487,535,pan-cancer mRNA,CTRPv2,dacarbazine,AAC,-0.000867606757160087,0.980331045699966,260,pan-cancer mRNA,gCSI,lapatinib,AAC,-0.00139816422119881,0.981159990176589,415,pan-cancer mRNA,GDSC1000,AS605240,AAC,0.00076373626259239,0.982951503149734,37,pan-cancer mRNA,CTRPv2,purmorphamine,AAC,-0.000638495598262244,0.987463197748992,575,pan-cancer mRNA,CTRPv2,BRD-K16130065,AAC,0.00121252395652419,0.987601780304702,114,pan-cancer mRNA,CTRPv2,MST-312,AAC,-0.000553312209949186,0.988287360559999,469,pan-cancer mRNA,CTRPv2,leptomycin B,AAC,-0.000525941804611935,0.988428489294062,421,pan-cancer mRNA,FIMM,GDC-0941,AAC,-0.00234718141302116,0.989800128339377,313,pan-cancer mRNA,CTRPv2,VER-155008,AAC,0.000446814701910469,0.991104185021655,719,pan-cancer mRNA,GDSC1000,PI-103,AAC,0.000345910678906121,0.991630044693215,558,pan-cancer mRNA,CTRPv2,BRD-A86708339,AAC,0.000559675800470073,0.991757889530262,99,pan-cancer mRNA,CTRPv2,BRD-K28456706,AAC,0.000413168291806816,0.991867605492986,125,pan-cancer mRNA,FIMM,Bryostatin 1,AAC,0.00103148174000395,0.994209469216137,188,pan-cancer mRNA,CTRPv2,ML083,AAC,0.000259461002651633,0.995184392563153,452,pan-cancer mRNA,FIMM,Pazopanib,AAC,0.00101778410831331,0.995537939678993,533,pan-cancer mRNA,CTRPv2,BRD-K03536150,AAC,-0.000204464033015818,0.996041948596881,104,pan-cancer mRNA,GDSC1000,XMD11-85h,AAC,-0.000214933479791833,0.996599090473334,742,pan-cancer mRNA,CTRPv2,selumetinib:MK-2206 (8:1 mol/mol),AAC,-6.92562064664917e-05,0.998557470895604,622,pan-cancer